by Erin | Dec 11, 2024 | Blog
State-based Prescription Drug Affordability Board’s (PDABs) have an important goal – to cut health care costs by reducing spending on prescription drugs. However, in an effort to do so, PDAB actions often overlook the complexities of America’s health care system and...
by Erin | Oct 25, 2024 | Blog
As states implement, or consider creating, prescription drug affordability boards with authority to cap pharmaceutical drug prices, a recent survey of independent pharmacists should serve as a warning about the unintended consequences of upper payment limits. ...
by Erin | Sep 25, 2024 | Blog
As noted in the Value of Care Coalition’s most recent blog post, Colorado and Maryland Prescription Drug Affordability Boards (PDAB) are both in the process of considering how to set upper payment limits (UPL) on certain drugs. While the timeline in Colorado remains...
by Erin | Sep 19, 2024 | Blog
Following years of fits and starts for Prescription Drug Affordability Board (PDAB) operations, advocates might be surprised to find that two states now seem to be in a race to implement processes for setting upper payment limits. In early September, PDABs met in both...
by Erin | Aug 16, 2024 | Blog
On Friday, August 9, the Maryland Prescription Drug Affordability Board released its draft Upper Payment Limit Action Plan. If the Maryland Prescription Drug Affordability Board determines that a drug “has led or will lead to affordability challenges for the State...
by Erin | Jul 31, 2024 | Blog
Health care payers are intensely focused on the cost of healthcare, particularly pharmaceutical costs. States, as large purchasers of health care, are seeking new and expanded ways to reduce these costs. One means they have recently begun to employ is prescription...
